Delivery Order SPE2DB24D9113-SPE2DB24FEPUN
Award Date 6/11/24
Potential Completion Date 7/3/24
Potential Value $3.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XOLAIR 150 MG/ML SYRINGE. The single-award, firm fixed-price contract has a ceiling value of $37,137.60 and an ultimate completion date of May 3, 2024. This delivery order is placed under DMS Pharmaceutical Group's indefinite delivery contract 4600082013 with the DLA, which has a total potential value of up to $4,999,999 through 2025. The...
- This is a $3,094.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The order is for the delivery of XOLAIR 150 MG/ML syringes, with a period of performance ending on July 17, 2024. The award is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to place delivery orders for a comprehensive range of...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,094.80 to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGE/ML and has an ultimate completion date of April 30, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, valued up to $4,999,999, that enables DLA to procure a broad range of pharmaceutical products and medical supplies to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of Xolair 150 mg/mL syringes, with a potential value of $37,137.60 and a completion date of January 12, 2024. The delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA, valued up to $5 million through December 2025, to provide a variety of pharmaceutical items...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, for the supply of XOLAIR 150 MG/ML SYRINGE. The contract is a firm fixed-price delivery order with a potential value of $27,853.20 and a completion date of February 22, 2024. This delivery order is placed against DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with DLA, contract 4600082013 under the SPE2DB program, valued at up to...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, with a completion date of March 13, 2024 and a potential value of $6,189.60. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency, contract 4600082013 under the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $7,737.00 and has an ultimate completion date of July 9, 2024. The contract is for the delivery of Xolair 150 mg/ml syringes, a specialty pharmaceutical product used to treat certain respiratory conditions. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC)...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGE/ML, with a ceiling value of $1,813.12 and a period of performance through May 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA, valued at...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, number SPE2DB24FZB70, to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide XOLAIR 150 MG/ML SYRINGEML. The $18,568.80 order has an ultimate completion date of April 16, 2024. This delivery order is part of a larger indefinite delivery contract, number SPE2DB22D9143, that DMS Pharmaceutical Group holds with DLA, valued at up to $4,999,999 through the end of 2025. The IDC enables DLA...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at up to $6,189.60, is for the supply of Xolair 150 mg/mL syringes to support the recurring medical needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which runs...